Neurogene Shares Surge 5.09% as Volatility Fades: What It Means for Investors
Neurogene’s NGNE stock rises 5.09% after a volatile month, hinting at renewed investor confidence amid breakthrough genetic medicine developments.
3 minutes to read
NEUROGENE INC
Neurogene Inc (NGNE) Hits $25.40, Up 3.96% Amid Biotech Rally
NGNE stock hits $25.40, up 3.96%—see why Neurogene Inc’s biotech shares are trending and how they compare to peers.
2 minutes to read